Delay of ovulation by meloxicam in healthy cycling volunteers: A placebo-controlled, double-blind, crossover study

Journal of Clinical Pharmacology

Volumn 46, Issue 8, 2006, Pages 925-932

  Bata, M S ^a   Al Ramahi, M ^a   Salhab, A S ^a   Gharaibeh, M N ^a   Schwartz, Jill ^b  

^a UNIVERSITY OF JORDAN   (Jordan)

^b EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

Follicle rupture; Follicle size; Meloxicam; Progesterone; Ultrasound

Indexed keywords

LUTEINIZING HORMONE; MELOXICAM; PLACEBO; PROGESTERONE;

ABDOMINAL PAIN; ADULT; ARTICLE; BLOOD SAMPLING; BONE PAIN; CLINICAL OBSERVATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; CYCLING; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG SCREENING; FEMALE; FEMALE FERTILITY; HUMAN; ILIAC BONE; MENSTRUAL CYCLE; NORMAL HUMAN; OVARY FOLLICLE; OVARY HYPERTROPHY; OVULATION; PROGESTERONE BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SORE THROAT; TRANSVAGINAL ECHOGRAPHY; URINALYSIS;

ADULT; CONTRACEPTIVES, ORAL; CROSS-OVER STUDIES; CYCLOOXYGENASE 2 INHIBITORS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MENSTRUAL CYCLE; OVARIAN FOLLICLE; OVULATION; PROGESTERONE; REFERENCE VALUES; THIAZINES; THIAZOLES; TIME FACTORS;

EID: 33745878572     PISSN: 00912700     EISSN: 15524604     Source Type: Journal    
DOI: 10.1177/0091270006289483     Document Type: Article

References (31)

1. Noble S, Balfour JA. Meloxicam. Drugs. 1996;51:424-432.
2. Smith G, Roberts R, Hall C, Nuki G. Reversible ovulatory failure associated with the development of luteinized unruptured follicles in women with anti-inflammatory arthritis taking nonsteroidal anti-inflammatory drugs. Br J Rheumatol. 1996;35: 458-462.
3. Akil M, Amos RS, Stewart P. Infertility may sometimes be associated with NSAID consumption. Br J Rheumatol. 1996;35:76-78.
4. Mendonca L, Khamashta M, Nelson-Piercy C, Hunt BJ, Hughes GR. Nonsteroidal anti-inflammatory drugs as a possible cause for reversible infertility. Rheumatology. 2000;39:882.
5. Armstrong DT, Grinwich DL. Blockade of spontaneous and LH-induced ovulation in rats by indomethacin, an inhibitor of prostaglandin biosynthesis, Prostaglandins. 1972;1:21-36.
6. Lau IF, Saksena SK, Chang MC. Pregnancy blockade by indomethacin, an inhibitor of prostaglandin synthesis: its reversal by prostaglandins and progesterone in mice. Prostaglandins. 1973;4:795-803.
7. Espey LL, Stein VI, Dumitrescu J. Survey of anti-inflammatory agents and related drugs as inhibitors of ovulation in rabbits. Fertile Steril. 1982;38:238-247.
8. Akinlosotu BA, Verna OB. Detection of ovulation in goats by blood prostaglandins concentration. Am J Vet Res. 1983;44:1339-1343.
9. Duffy DM, Stouffer RL. Follicular administration of cyclooxygenase inhibitor can prevent oocyte release without alteration of normal luteal function in rhesus monkeys. Hum Reprod. 2002;17:2825-2831.
10. Killick S, Elestein M. Pharmacologic production of luteinized unruptured follicles by prostaglandin synthetase inhibitors. Fetil Steril. 1987;47:773-777.
11. Matsumoto H, Ma W, Smallery W, Trazaskos J, Breyer RM, Dey SK. Diversification of cyclooxygenase-2-derived prostaglandin in ovulation and implantation. Biol Reprod. 2001;64:1557-1565.
12. Brannstrom M, Norman RJ. Involvement of leukocytes and cytokines in the ovulatory and corpus luteum function. Hum Reprod. 1993;8:1762-1765.
13. Vane JR, Bakhle YS, Botting RM. Cyclooxygenase 1 and 2. Ann Rev Pharamcol Toxicol. 1998;38:97-120.
14. Smith WL, De Witt DL, Garavito RM. Cyclooxygenases: structural, cellular, and molecular biology. Ann Rev Biochem. 2000;69:145-182.
15. Dinchuk JE, Car BD, Focht RJ, et al. Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II. Nature. 1995;378:406-409.
16. Lim H, Dey S. Prostaglandin E-2 receptor subtype EP2 gene expression in the mouse uterus coincides with differentiation of the luminal epithelium. Endocrinology. 1997;138:4599-4606.
17. Lim H, Paria BC, Das SK, Dinchuk JE, Langenhach R, Trzaskos JM, Dey SK. Multiple female reproductive failures in cyclooxygenase2-deficient mice. Cell. 1997;91:197-208.
18. Langenbach R, Morham SG, Tiano HF, et al. Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid inflammation and indomethacin-induced gastric ulceration. Cell. 1995;83:483-492.
19. Pall M, Friden B, Brannstrom M. Induction of delayed follicular rupture in the human by the selective COX-2 inhibitor rofecoxib. Hum Reprod. 2001;16:1323-1328.
20. Salhab AS, Gharaibeh MN, Shomaf MS, Amro BI. Meloxicam inhibits rabbit ovulation. Contraception. 2001;63:329-333.
21. Salhab AS, Amro BL, Shomaf MS. Further investigation on meloxicam contraceptivity in female rabbits: luteniznig unruptured follicles, a microscopic evidence. Contraception. 2003;67:485-489.
22. Coetsier T, Dhont M. Complete and partial luteinized unruptured follicle syndrome after ovarian stimulation with clomiphene citrate/human menopausal gonadotrophin/human chorionic gonadotrophin. Hum Reprod. 1996;11:583-587.
23. Dasandi B, Shivaprakash, Saroj H, Bhat KM. LC determination and pharmacokinetics of meloxicam J Pharm Biomed Anal. 2002;28:999-1004.
24. Athanasiou S, Bourne T, Khalid A, et al. Effects of indomethacin on follicular structure, vascularity, and function over the periovulatory period in women. Fert Steril. 1996;65:556-560.
25. Landgren BM, Unen AL, Dicfalusy E. Hormonal profile of the cycle in 68 normal menstruating women. Acta Endocrinol. 1980;94:89-98.
26. Turk D, Busch U, Heinzel G, Narjes H. Clinical pharmacokinetics of meloxicam. Arzheimittel forschung. 1997;47:253-258.
27. Hosie J, Distel M, Bluhmki E. Efficacy and tolerability of meloxicam versus piroxicam in patients with osteoarthritis of the hip or knee: a six-month double-blind study. Clin Drug Invest. 1997;13:175-184.
28. Distel M, Mueller C, Bluhimki E, Fries J. Safety of meloxicam, a global analysis of clinical trials. Br J Rheumatol. 1996;35(suppl):68-77.
29. Lemmel EM, Bolten W, Burgos-Vergas R, Platt P, Nissila M, Sehlberg D. Efficacy and safety of meloxicam in patients with rheumatoid arthritis. J Rhematol. 1997;24:282-290.
30. Altman R, Luciardi HL, Muntaner J, et al. Efficacy assessment of meloxicam, a preferential cyclooxygenase-2 inhibitor, in acute coronary syndromes without ST-segment elevations: the nonsteroidal anti-inflammatory drugs in unstable angina treatment-2 (NUT-2) pilot study. Circulation. 2002;106:191-195.
31. Hamilton C, Wetzels L, Evers J, Hoogland H, Muijtjens A, Haan J. Follicle growth curves and hormonal patterns in patients with the luteinized unruptured follicle syndrome. Fert Steril. 1985;43:541-548.